Research & Projects

ESCMID Panorama

ESCMID Study Group for Antimicrobial Stewardship - ESGAP

News & Activities

11 May 2017

ESGAP has a new name

Antimicrobial stewardship has now become standard terminology (in English) worldwide to describe a set of actions/a programme aiming at ensuring responsible antibiotic use. ESGAP has changed its name accordingly from ESCMID Study Group for Antibiotic Policies to ESCMID Study Group for Antimicrobial stewardshiP.

EUCIC, ESGAP and EUCAST launched a European survey to explore in which countries selective reporting of antibiotic susceptibility testing results has already been implemented at a large scale (regional, national) and how it has been organized. The survey “Selective reporting of antibiotic susceptibility test results in European countries: an ESCMID cross-sectional survey” has now been published in the International Journal of Antimicrobial Agents.
IJAA website

The European Committee on Infection Control (EUCIC) and the ESCMID Study Group for Antibiotic Policies (ESGAP) organize a number of activities to promote prudent use of antibiotics in Europe. They include events at healthcare institutions and public campaigns on antimicrobial resistance (AMR), surveillance and antibiotic stewardship programmes in Moldova, Turkey, Spain, Cyprus and the Netherlands.

06 September 2016

ESGAP/SPILF AB-Duration survey 2016

ESGAP and SPILF (the French ID society) have conducted the AB-Duration survey, which is closed now.

We aimed to explore current practices regarding durations of antibiotic treatments in common infections, in order to get an international picture on the topic. The duration of antibiotic therapy is indeed not completely solved for many infectious syndromes.

The survey was intended for senior or trainee specialists in infectious diseases or clinical microbiology, clinical pharmacists, or any healthcare professional part of an antimicrobial stewardship team worldwide, provided that these professionals regularly give advice on antibiotic prescriptions (outside their own department).

Results of this survey will now be analyzed and published here at a later time point. We will keep you informed.

- Prof. Céline Pulcini, on behalf of the AB-Duration scientific committee (Bojana Beovic, Guillaume Béraud, Bernard Castan, Oliver J. Dyar, Rémy Gauzit Philippe Lesprit, Gabriel Macheda, Céline Pulcini, Pierre Tattevin, and Nathalie Thilly)

01 September 2016

ESGAP AntibioLegalMap survey 2016

The ESGAP AntibioLegalMap survey is closed now.

We aim to explore the following topics, in order to get an international picture and to raise awareness on these issues:

  • How are consultations performed by antibiotic experts organised in different countries?
  • What is the legal liability (=responsibility) associated with antibiotic prescribing and advising?
  • How might this liability impact on clinical decisions?

Results of this survey will now be analyzed and published here at a later time point. We will keep you informed.

- Prof. Céline Pulcini and Prof. Bojana Beović, on behalf of the ESGAP AntibioLegalMap scientific committee

ESCMID researchers conducted a survey – supported by ESGAP, the elderly infections group (ESGIE) and the nosocomial infections group (ESGNI) – to assess the current status of infectious diseases (ID), clinical microbiology (CM) and infection control (IC) staffing in hospitals. They found that currently no standard of physician staffing for ID/CM/IC in hospitals is available. More than half of respondents estimated that additional staffing is needed for appropriate IC or ID management.

The researchers conclude that a ratio of 1.21/100 beds will serve as an informed point of reference enabling antibiotic stewardship programmes and infection surveillance.

Clin Microbiol Infect. 2016 Jun 29. pii: S1198-743X(16)30214-2. doi: 10.1016/j.cmi.2016.06.014.

01 December 2015
EUCIC, ESGAP, EUCAST conduct antibiotic susceptibility testing survey

The three groups will start conducting a European survey this week to explore in which countries selective reporting of antibiotic susceptibility testing results has been already implemented on a large scale (regional, national) and how it has been organized. For this purpose, a questionnaire survey will be sent out to national contacts in the first week of December. We look forward to active participation of the national representatives.

If you have specific question in relation to this survey regarding our groups please contact us:

  • Saturday, 10 May 2014
    08.45 - 10.45 (Hall B)
    Educational Workshop 01: Infection prevention and management in long-term care facilities, organised jointly with the ESCMID Study Group for Infections in the Elderly (ESGIE) and the ESCMID Study Group for Nosocomial Infections (ESGNI).
  • Monday, 12 May 2014
    13.15 - 14.15 (Room 132)
    ESGAP Business Meeting: All interested persons are cordially invited to join the meeting and plan future Study Group activities.


Due to recent changes in the constitution of ESCMID all study group members have to rejoin. I would be most grateful if you could use the following link to rejoin ESGAP.

Membership is open to ESCMID members and you do not need to reside in Europe or the EU. Joining ESGAP has no additional membership fee on top of the ESCMID membership fee.

If you are already an ESCMID member please join ESGAP through the following link.


If you are not an ESCMID member yet you will have to join ESCMID through the following link.

Become an ESCMID member

and then you can join ESGAP through the above link.

ESGAP is an active ESCMID study group that promotes  awareness and learning about antimicrobial stewardship through educational activity such as pre-ECCMID postgraduate courses, support of regional meetings and now soon through a new website that aims to provide a virtual learning community for health care professional interested in stewardship.

We hope you will take a small amount of time to either rejoin our group [welcome back] and to new members you are most welcome to join us. Please also communicate this message to interested colleagues and where relevant, please contact other colleagues through your local, regional or national organization contacts.

We are keen to involve all of you in a range of educational and research activities around the important topic of stewardship.

On behalf of the ESGAP executive committee I very much look forward to you joining us.

Yours sincerely

Dilip Nathwani
Current Chair of ESGAP

Worldwide Antimicrobial Stewardship Survey

Investigators from ESGAP (ESCMID Study Group for Antibiotic Policies) in conjunction with the ISC (International Society for Chemotherapy) Antimicrobial Stewardship Working Group have developed an international survey of antimicrobial stewardship activity and capability.

The survey is based on previous national surveys from around the world, and has been piloted and refined across all five continents.  The results will be presented at international meetings and data will be available here soon to allow continental, national and local benchmarking of antimicrobial stewardship programmes.

Colistin Global Survey

The ESGAP Executive Committee supported and recommended the following survey (closed end of 2011):

Dear ESGAP members:

Severe multi-drug resistant Gram-negative infections are becoming more common worldwide. These bacteria are often still sensitive to the older antibiotics colistin or polymyxin B. These drugs are now being used more commonly. Unfortunately, little is known about how these drugs are dosed optimally and with what other drugs to combine them.

Dr Heiman Wertheim - from Oxford University, Hanoi, Viet Nam, one very active member of our ISC Antimicrobial Stewardship working group (ISC ABS WG) -, has organized - in collaboration with ReAct, GARP and the ISC ABS WG - an international survey to know more about colistin and polymixin B utilisation. We are now inviting ESGAP to be an active collaborator to keep on with this global initiative.

Taking into account the high impact of MDR Gram-negative rods, and that these drugs are in a great majority of cases the only option for treatment, we would really appreciate both your participation and your collaboration in disseminating this global survey. 

For questions or comments, please contact Dr Heiman Wertheim, University of Oxford

Gabriel Levy Hara MD
Antimicrobial Stewardship Working Group
International Society of Chemotherapy

ABC-Calc 2011: A new version of ABC-Calc has been developed and is being piloted before it is finally launched.

This version is a completely new implementation of the tool. It has been transformed into a standalone application (it is not any more a excel file). The new functionalities are the possibility to read an excel file in input, in addition to enter data manually and to export the results into an excel file. The scope of the antimicrobials managed by ABC-Calc has been extended to, notably, antimycotics and antivirals. The tool is developed in java and is multi platform.
We invite ESGAP members to test the new version.

Please contact Arno Muller and he will e-mail instructions to download and use the new version.

Repetition of the European Survey on Antibiotic Shortages in EU Hospitals

ESGAP conducted a previous survey with the results presented at the 17th ECCMID/ICC, Munich, Germany, 31 March - 4 April 2007:

Survey Results

A knowledge and networking resource from ESGAP!

Download the latest Annual Report.